CAN CSA Z11137-1-07: Radiation Sterilization of Health Care Products – Technical Requirements and Compliance Guide

CAN CSA Z11137-1-07 is the Canadian adoption of the international standard ISO 11137-1:2006, governing the sterilization of health care products by radiation. Developed by the Canadian Standards Association (CSA), the standard establishes requirements for the development, validation, and routine control of a sterilization process for medical devices using ionizing radiation. This article details its scope, technical requirements, implementation highlights, and compliance notes.

Scope of CAN CSA Z11137-1-07

The standard applies to sterilization processes that use gamma radiation, electron beam, or X-ray radiation for the sterilization of single-use and reusable health care products. It covers both initial establishment of the sterilization dose and subsequent process validation, routine monitoring, and requalification. The standard is intended for manufacturers, regulatory bodies, and sterilization service providers.

Technical Requirements

Dose Setting Methods

The standard defines two primary methods for establishing the sterilization dose:

• Method 1 (Bioburden-based): Requires determination of bioburden on product units and use of sterilization dose tables to select an appropriate dose achieving a sterility assurance level (SAL) of 10⁻⁶.
• Method 2 (VD_max): Uses incremental dose exposures to establish doses that yield an SAL of 10⁻⁶ or 10⁻⁵, depending on product criticality.

Process Validation

Validation includes installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ). Dose mapping in product containers and load configurations is mandatory. Maximum and minimum absorbed doses must be within predefined limits.

Routine Control and Monitoring

During routine processing, dosimeters are placed at representative locations. The key parameters to monitor include:

All deviations must be investigated and recorded as per the quality management system requirements.

Implementation Highlights

Sterility Assurance Level (SAL)

The standard mandatorily targets an SAL of 10⁻⁶ for invasive medical devices. For non-invasive products, an SAL of 10⁻⁵ may be acceptable if justified by risk assessment.

Bioburden Information

Bioburden determination must follow documented methods (e.g., ISO 11737-1) and account for product geometry, material compatibility, and recovery efficiency.

Maximum Acceptable Dose

The standard requires that the product withstand the maximum dose without compromising function or safety. Dose tolerance testing is part of the product qualification phase.

Periodic Requalification

Requalification of the sterilization process must be performed at intervals not exceeding one year, or after any significant change to the product, packaging, or facility.

Compliance and Auditing Notes

Regulatory Context

In Canada, adherence to CAN CSA Z11137-1-07 is recognized by Health Canada as evidence of conformity for sterility claims under the Medical Devices Regulations (SOR/98-282). The standard may be used alongside other CSA sterilization standards (e.g., Z11137-2, Z11137-3).

Documentation Requirements

Auditors from accredited bodies (e.g., SCC, NIST) will look for:

• Completed validation protocol and report
• Dose mapping records for all representative loads
• Bioburden test records and trend analysis
• Change control documentation
• Training records for operators

Transition to ISO 11137-1:2025

Note that the international standard has been revised. Although CAN CSA Z11137-1-07 remains current in Canada, manufacturers are advised to monitor updates to align with the latest practices. Contact CSA Group for revision status.

In summary, CAN CSA Z11137-1-07 provides a rigorous framework for radiation sterilization in healthcare. Implementing its requirements helps ensure patient safety, regulatory compliance, and product efficacy.

Frequently Asked Questions